Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2011

Conditions
Neoplasms, Uterine CervixMetastatic Cervical Cancer
Interventions
DRUG

pazopanib (GW786034)

DRUG

lapatinib (GW572016)

Trial Locations (63)

7

GSK Investigational Site, Dublin

1000

GSK Investigational Site, Brussels

1200

GSK Investigational Site, Brussels

1878

GSK Investigational Site, Quilmes

3000

GSK Investigational Site, Santa Fe

GSK Investigational Site, Leuven

4000

GSK Investigational Site, San Miguel de Tucumán

8800

GSK Investigational Site, Roeselare

9000

GSK Investigational Site, Ghent

10016

GSK Investigational Site, New York

10117

GSK Investigational Site, Berlin

10330

GSK Investigational Site, Bangkok

10367

GSK Investigational Site, Berlin

11619

GSK Investigational Site, Tallinn

13273

GSK Investigational Site, Marseille

14076

GSK Investigational Site, Caen

20141

GSK Investigational Site, Milan

28007

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Marid

30912

GSK Investigational Site, Augusta

31008

GSK Investigational Site, Pamplona

33076

GSK Investigational Site, Bordeaux

37403

GSK Investigational Site, Chattanooga

38320

GSK Investigational Site, La Laguna (Santa Cruz de Tenerife)

39108

GSK Investigational Site, Magdeburg

40002

GSK Investigational Site, Khon Kaen

43214

GSK Investigational Site, Columbus

44106

GSK Investigational Site, Cleveland

50200

GSK Investigational Site, Chiang Mai

51003

GSK Investigational Site, Tartu

59020

GSK Investigational Site, Lille

66113

GSK Investigational Site, Saarbrücken

67085

GSK Investigational Site, Strasbourg

70124

GSK Investigational Site, Bari

73104

GSK Investigational Site, Oklahoma City

75390

GSK Investigational Site, Dallas

80131

GSK Investigational Site, Napoli

80337

GSK Investigational Site, Munich

86100

GSK Investigational Site, Campobasso

90033

GSK Investigational Site, Los Angeles

92868

GSK Investigational Site, Orange

94805

GSK Investigational Site, Villejuif

110096

GSK Investigational Site, New Delhi

380016

GSK Investigational Site, Ahemdabad

575001

GSK Investigational Site, Mangalore

695011

GSK Investigational Site, Trivandrum

94305-5317

GSK Investigational Site, Stanford

02115

GSK Investigational Site, Boston

87131-5276

GSK Investigational Site, Albuquerque

C1405CUB

GSK Investigational Site, Capital Federal

C1185AAT

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

Q8300HDH

GSK Investigational Site, Neuquén

S2000KZE

GSK Investigational Site, Rosario

T2N 4N2

GSK Investigational Site, Calgary

V5Z 4E6

GSK Investigational Site, Vancouver

L8V 5C2

GSK Investigational Site, Hamilton

M5G 2M9

GSK Investigational Site, Toronto

H2L 4M1

GSK Investigational Site, Montreal

06120

GSK Investigational Site, Halle

Unknown

GSK Investigational Site, Cork

CP 14080

GSK Investigational Site, Mexico City

08036

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY